1,2-Dichloro-3-isocyanatobenzene → 1-(5-tert-butyl-3-(2,2-dimethyl-3-oxopiperazine-1-carbonyl)-1H-pyrrol-2-yl)-3-(2,3-dichlorophenyl)urea
Reaktionsgleichung
[NH2:1][C:2]1[NH:3][C:4]([C:18]([CH3:21])([CH3:20])[CH3:19])=[CH:5][C:6]=1[C:7]([N:9]1[CH2:14][CH2:13][NH:12][C:11](=[O:15])[C:10]1([CH3:17])[CH3:16])=[O:8].[Cl:22][C:23]1[CH:28]=[CH:27][CH:26]=[C:25]([N:29]=[C:30]=[O:31])[C:24]=1[Cl:32]>C1COCC1>[C:18]([C:4]1[NH:3][C:2]([NH:1][C:30]([NH:29][C:25]2[CH:26]=[CH:27][CH:28]=[C:23]([Cl:22])[C:24]=2[Cl:32])=[O:31])=[C:6]([C:7]([N:9]2[CH2:14][CH2:13][NH:12][C:11](=[O:15])[C:10]2([CH3:16])[CH3:17])=[O:8])[CH:5]=1)([CH3:21])([CH3:20])[CH3:19]Komponenten
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
To 4-(2-amino-5-tert-butyl-1H-pyrrole-3-carbonyl)-3,3-dimethyl-piperazin-2-one 7 (60 mg, 0.21 mmol) in THF (1 mL) was added 1,2-dichloro-3-isocyanatobenzene (58 mg, 0.31 mmol) in THF (1 mL). The resulting reaction mixture was stirred at room temperature for 1 h, at which time, TLC indicated the completion of the reaction. The solvent was then removed in vacuo, and the residue was purified by prep. TLC (EtOAc/MeOH: 9.5/0.5) to provide 1-(5-tert-butyl-3-(2,2-dimethyl-3-oxopiperazine-1-carbonyl)-1H-pyrrol-2-yl)-3-(2,3-dichlorophenyl)urea (14.6 mg, 15%) as off-white solid. 1H NMR (400 MHz, CD3OD): δ (ppm) 7.93 (t, J=4.9 Hz, 1H), 7.20 (q, J=1.9 Hz, 2H), 5.68 (s, 1H), 3.87 (t, J=5.1 Hz, 2H), 3.44 (t, J=5.0 Hz, 2H), 1.75 (s, 6H), 1.25 (s, 9H).
Aufarbeitung
- customThe resulting reaction mixture
- customthe completion of the reaction
- customThe solvent was then removed in vacuo
- customthe residue was purified by prep
Quellen und Nachweise
- ORD-Eintrag
- ord-974a177645f54e899abbc1a755582b13
- Quelldatensatz
- uspto-grants-2010_06
- Patentnummer
- US07741479B2
Notizen zur Reaktion
Wird geladen…